# Livmarli

NDC: 79378-210
Generic name: maralixibat chloride
Labeler / Manufacturer: Mirum Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250410

FDA application: NDA219485

## Active ingredients

- MARALIXIBAT CHLORIDE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"79378-210"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=79378-210
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=64000394-1ef6-4e76-8ba8-11f25ba1b167